Synovis tissue repair technology buoys sales for 2010

December 2, 2010 By MedCity News Leave a Comment

Synovis Life Technologies Inc. (NASDAQ:SYNO) may not have generated many headlines this year, but the St. Paul, Minn.-based company has quietly produced a rather impressive annual performance.

This is especially the case when compared to what remains of the North Star State’s shrinking, publicly traded medical device sector.

In a year when ATS Medical and AGA Medical were sold, and SurModics Inc. (NASDAQ:SRDX) sucked wind, Synovis’ fiscal 2010 revenues soared 18 percent to $68.6 million from $58.2 million a year ago, thanks to strong growth from its core Veritas soft tissue repair technology, according to the company.

“We are pleased with our overall revenue results, [which are] … especially significant in light of the economic climate and the aggressive reaction by healthcare providers to evolving healthcare reform legislation,” CEO Richard Kramp said in a statement. “Synovis’ double-digit revenue growth speaks favorably of our people, our products and our markets. We have robust plans in place to continue on a strong growth trajectory in 2011 and beyond — fueled by our high potential products, particularly Veritas.”

Synovis has seen countless comebacks and reinventions in its 25-year history. But the company seemingly has found its winning niche: producing implantable biomaterial that helps the body repair and regenerate soft tissue.

Synovis’ signature technology, Veritas, consists of converting cow tissue into a type of scaffolding that attracts the human body’s own cells and blood vessels, enabling it to remodel the repaired tissue type. Synovis hopes doctors will use Veritas to repair kidneys, bladders, breasts, and eventually, hearts.

For the year, Veritas sales rose 64 percent to $14.4 million compared to 2009. Veritas accounted for 21 percent of fiscal 2010 revenue, up from 15 percent the previous year.

If there’s one blemish on Synovis’ 2010 performance, profits fell 26 percent to $4.9 million, or 43 cents a share, from $6.6 million, or 56 cents a share, last year.

But the profit decline was due to beefed up spending on sales and marketing, and investments in research, development and new technologies, including microsurgery products and orthopedic/wound care treatments.

For the full year, microsurgical revenue totaled $11.0 million, a 27 percent increase over 2009. Orthopedic and wound product sales totaled $685,000 for the fiscal fourth quarter, up 16 percent from the third quarter. Synovis entered the orthopedic/wound care market when it acquired Pegasus Biologics in July 2009 and relaunched the portfolio earlier this year.

Investors have rewarded Synovis’ performance, boosting the stock about 23 percent this year to just above $16 a share.

In other life science industry financial news, Milford, Mass.-based SeraCare Life Sciences Inc. (NSDQ:SRLS) reported profits of $2.0 million, or 11 cents per diluted share, on revenue of $13.3 million during its fourth quarter ending Sept. 30. That compares with profits of $1.4 million, or 8 cents per diluted share, on revenue of $12.5 million during the same period last year. Four the year, the company’s logged profits of $6.7 million, or 35 cents per share, on revenue of $50.4 million. That compares with a loss of $15.4 million, or 83 cents per share, on revenues of 44.4 million for its 2009 fiscal year.

Integer expands to Israel
Integer Holdings (NYSE:ITGR) today announced it has acquired medtech manufacturer Inomec, formally establishing its presence in Israel. The Plano, Texas-based company said the acquisition will enable it to create an R&D and sales center in the region and adds important catheter design, clinical and pilot manufacturing capabilities to its portfolio. “Acquiring Inomec strengthens our research… […]
Why non-magnetic capacitors matter in medical imaging
The quality of an MRI image depends on the homogeneity, or uniformity, of the magnetic field. Component material choice is paramount; even the smallest trace of magnetism inside an MRI scanner can disrupt the field and harm the quality of an MRI image. Peter Matthews, Knowles Precision Devices Magnetic resonance imaging (MRI) equipment uses a… […]
This heart valve can adapt as a child grows
Boston Children’s Hospital is touting a new design that could allow children to maintain the same prosthetic heart valve until adulthood, which could also benefit adults with heart valve defects. Current prosthetic heart valves implanted in children with congenital heart disease are fixed in size, which requires multiple open-heart surgeries during childhood to replace the… […]
Simulating Reality With 3D Printed Medical Models
The medical breakthroughs that cure disease, restore health and prolong life aren’t created in a vacuum. They rely on the convergence of visionary minds and cutting-edge technology. This case study explores how the Jacobs Institute is leveraging 3D printing technology from Stratasys® to elevate medical device innovation and training, using ultrarealistic anatomical models created by… […]
These ‘smart’ bandages could heal chronic woulds
UConn biomedical engineers are touting a wirelessly controlled “smart” bandage and corresponding platform for delivering medications to chronic, non-healing wounds. UConn’s School of Dental Medicine, School of Medicine and School of Engineering comprise the biomedical engineering department, which contributed to developing the smart bandage. Ali Tamayol, an associate professor at UConn, led the development of… […]
How to cook up a successful medtech company
New medical device companies need much more than money to get their businesses started. A medtech-specific accelerator can help with seed funding and positioning for a Series A round. Shai Policker, MEDX Xelerator As we dive into 2020, the medtech sector will continue to offer tremendous opportunity for innovators and investors alike, with growth projected… […]
Could this patch help mend a broken heart?
Researchers in Ireland have developed a prototype patch that they say does the same job as crucial aspects of heart tissue. The patch was designed to withstand the mechanical demands of heart tissue and mimic the electrical signaling properties that allow the heart to pump blood throughout the body. The researchers believe it brings medtech… […]
Black History Month: This inventor laid the foundation for today’s pacemakers
Most people in medtech know of Earl Bakken’s contributions to pacemakers and cardiac rhythm devices, but without Otis Boykin, pacemakers wouldn’t have the pacing technology they do today. Boykin, an African-American inventor and engineer, had a special interest in resistors. His mother died from heart failure when he was 1 year old. Thirty-one years later,… […]
Could this 3D bioink printer speed wound healing?
The University of Toronto is touting a new handheld 3D printer that can deposit sheets of skin to cover burn wounds and accelerate the healing process. A study, led by Richard Cheng under the supervision of Axel Guenther, published in Biofabrication revealed that the 3D printer completed successful in-vivo trials on full-thickness wounds, according to a report… […]
8 types of FDA-approved devices that treat the heart
Just starting to learn about all of the medical devices out there for treating cardiovascular diseases? The U.S. FDA has a good, basic roundup on its website of the most common types of cardiovascular devices it regulates. Here’s the list, along with the FDA’s descriptions: 1. Automated external defibrillators (AEDs) “Portable and automatic, these devices… […]
Medtronic seeks to boost surgical robotics play with Digital Surgery acquisition
Medtronic (NYSE:MDT) announced today that it has acquired Digital Surgery (London), a privately-held pioneer in surgical artificial intelligence, data and analytics, and digital education and training. Financial terms of the deal were not disclosed. Medtronic said the purchase will strengthen its robot-assisted surgical platform and its broader portfolio. The medical device giant is making a big play… […]